SERMONIX PHARMACEUTICALS Trademark

Trademark Overview

On Wednesday, April 20, 2016, a trademark application was filed for SERMONIX PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the SERMONIX PHARMACEUTICALS trademark a serial number of 87007615. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 28, 2019. This trademark is owned by Sermonix Pharmaceuticals LLC. The SERMONIX PHARMACEUTICALS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparation for post-menopausal women's health, namely, to prevent and/or treat breast cancer, osteoporosis and vulvovaginal atrophy

Consulting services in the field of pharmaceutical research
sermonix pharmaceuticals

General Information

Serial Number87007615
Word MarkSERMONIX PHARMACEUTICALS
Filing DateWednesday, April 20, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 28, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 2, 2016

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"PHARMACEUTICALS"
Description of MarkThe mark consists of a series of circles in a vertical line next to another vertical line with another horizontal line intersecting at the center, with a circle above, followed by the wording "SERMONIX PHARMACEUTICALS".
Goods and ServicesPharmaceutical preparation for post-menopausal women's health, namely, to prevent and/or treat breast cancer, osteoporosis and vulvovaginal atrophy
Goods and ServicesConsulting services in the field of pharmaceutical research

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 25, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 25, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSermonix Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressColumbus, OH 43209
Party NameSermonix Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressColumbus, OH 43213

Trademark Events

Event DateEvent Description
Monday, October 28, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 28, 2019ABANDONMENT - NO USE STATEMENT FILED
Wednesday, June 5, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 3, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, February 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 4, 2019EXTENSION 5 GRANTED
Friday, January 25, 2019EXTENSION 5 FILED
Monday, February 4, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 25, 2019TEAS EXTENSION RECEIVED
Thursday, August 30, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 28, 2018EXTENSION 4 GRANTED
Tuesday, August 28, 2018EXTENSION 4 FILED
Tuesday, August 28, 2018TEAS EXTENSION RECEIVED
Tuesday, February 27, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 23, 2018EXTENSION 3 GRANTED
Friday, February 23, 2018EXTENSION 3 FILED
Friday, February 23, 2018TEAS EXTENSION RECEIVED
Thursday, September 14, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 12, 2017EXTENSION 2 GRANTED
Tuesday, September 12, 2017EXTENSION 2 FILED
Tuesday, September 12, 2017TEAS EXTENSION RECEIVED
Wednesday, August 30, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 30, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, February 11, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 9, 2017EXTENSION 1 GRANTED
Thursday, February 9, 2017EXTENSION 1 FILED
Thursday, February 9, 2017TEAS EXTENSION RECEIVED
Tuesday, September 27, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 2, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 2, 2016PUBLISHED FOR OPPOSITION
Wednesday, July 13, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 27, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, June 20, 2016ASSIGNED TO LIE
Monday, June 13, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 13, 2016EXAMINER'S AMENDMENT ENTERED
Monday, June 13, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 13, 2016EXAMINERS AMENDMENT E-MAILED
Monday, June 13, 2016EXAMINERS AMENDMENT -WRITTEN
Monday, June 13, 2016ASSIGNED TO EXAMINER
Tuesday, April 26, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, April 25, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, April 23, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharmaceuticals sermonix pharmaceutical vulvovaginal osteoporosis atrophy consulting research field services cancer treat